SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is surging as investors react to the successful Artemis II mission and growing anticipation surrounding potential upcoming lunar contracts. The community is actively discussing the stock's significant momentum, potential for a short squeeze, and its emergence as a key player in the expanding private space infrastructure sector.

Figma, Inc. is an AI-powered design platform that enables seamless collaboration across the entire product development lifecycle. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is facing heavy selling pressure amid a broader market rotation out of high-multiple software stocks, with investors weighing concerns over long-term AI disruption against its strong product retention. While many traders see the current weakness as an overreaction and a potential accumulation opportunity, sentiment remains divided as the community debates whether the stock is finding a bottom or heading toward lower valuations.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is experiencing significant upward momentum driven by a $2 billion strategic investment from Nvidia aimed at bolstering AI infrastructure and cloud connectivity. The community is actively discussing the stock's transition from a standard semiconductor play to a critical AI infrastructure bet, with many investors anticipating further price appreciation as optics and custom AI chips become essential components for hyperscalers.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Menlo Park, CA.

Snowflake Inc

Snowflake is facing significant volatility as investors weigh strong quarterly growth and record contract signings against concerns regarding AI-driven SaaS disruption and cautious guidance. The stock is currently caught in a broader software sector selloff, with community sentiment deeply divided between long-term bulls highlighting data infrastructure demand and bears pointing to technical breakdowns, insider selling, and the threat of next-generation AI models.

Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. The company was founded by Kevin D. Bunker and Cam Gallagher on December 23, 2014 and is headquartered in San Diego, CA.

Zentalis Pharmaceuticals Inc

Zentalis Pharmaceuticals is capturing significant investor attention as the stock experiences high volatility and speculative volume, fueled by anticipatory chatter regarding an upcoming clinical data readout. The community remains deeply divided, with some traders highlighting the potential for a momentum-driven breakout and institutional accumulation, while skeptics warn of ongoing cash burn and the speculative nature of its current clinical trial timeline.

Maulcoin

Maulcoin is trending as a community-driven project that is actively rallying supporters to increase volume and engagement while waiting for technical issues regarding its ticker and chart integration to be resolved. The community, led by an active developer, positions the token as a transparent, long-term alternative to typical "rug pull" memecoins and is aggressively pushing for higher market capitalization and broader platform visibility.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is trending following the company's resumption of share repurchases for the first time in two years, a move aimed at signaling management's confidence in the stock's intrinsic value. Community discussion remains polarized, with some investors praising the stock as a defensive fortress due to its record cash pile, while others express frustration over the company's lack of dividend payments and perceived lack of growth compared to broader market indices.

GraniteShares ETF Trust - GraniteShares 2x Long NBIS Daily ETF

GraniteShares 2x Long NBIS Daily ETF

The GraniteShares 2x Long NBIS Daily ETF (NBIL) is trending as traders utilize the vehicle to capture leveraged exposure to the price movements of Nebius Group (NBIS). Community members are actively sharing their swing-trading strategies and entry points, driven by both technical setups and high expectations for potential growth in the underlying stock.

iShares Trust - iShares Expanded Tech-Software Sector ETF

iShares Expanded Tech-Software Sector ETF

The iShares Expanded Tech-Software Sector ETF (IGV) is experiencing intense volatility as investors debate whether AI advancements from companies like Anthropic will disrupt traditional SaaS business models or if the recent sell-off represents a generational buying opportunity. Community sentiment is deeply divided, with many traders pointing to high short interest and technical support levels as signs of a potential bottom, while others express concern over long-term structural risks to software valuations.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassian is trending as institutional investors aggressively de-risk from the enterprise SaaS sector, with sentiment pressured by fears that generative AI tools could disrupt traditional workflow management models. Despite persistent selling and fresh 52-week lows, the community remains deeply divided between those viewing the stock as a structurally broken "value trap" and contrarian investors who argue the platform's deep integration and enterprise switching costs provide a durable moat against AI-native competition.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Hennion & Walsh Asset Management Inc. Has $3.37 Million Holdings in ProKidney Corp. $PROK

Hennion & Walsh Asset Management Inc. lifted its stake in shares of ProKidney Corp. (NASDAQ:PROK - Free Report) by 63.5% in the 4th quarter, according to its most recent Form 13F filing with the...

ProKidney (NASDAQ:PROK) Shares Up 5.9%  - Here's Why

ProKidney (NASDAQ:PROK) Trading 5.9% Higher - What's Next...

ProKidney (NASDAQ:PROK) Trading Down 7.6% - Here's What Happened

ProKidney (NASDAQ:PROK) Stock Price Down 7.6% - Should You Sell...

Q2 Earnings Forecast for ProKidney Issued By HC Wainwright

ProKidney Corp. (NASDAQ:PROK - Free Report) - Stock analysts at HC Wainwright issued their Q2 2026 earnings per share (EPS) estimates for shares of ProKidney in a research note issued on Thursday, March 19th. HC Wainwright analyst J. Pantginis expects that the company will post earnings per share of...

ProKidney Corp. (NASDAQ:PROK) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of ProKidney Corp. (NASDAQ:PROK - Get Free Report) have earned a consensus rating of "Moderate Buy" from the eight ratings firms that are presently covering the firm, MarketBeat reports. Two...

ProKidney (NASDAQ:PROK) Cut to Sell at Wall Street Zen

Wall Street Zen cut ProKidney from a "hold" rating to a "sell" rating in a research note on Saturday...

Equities Analysts Set Expectations for ProKidney Q1 Earnings

ProKidney Corp. (NASDAQ:PROK - Free Report) - Equities research analysts at HC Wainwright issued their Q1 2026 earnings estimates for ProKidney in a research report issued on Thursday, March 19th. HC Wainwright analyst J. Pantginis forecasts that the company will post earnings of ($0.12) per share f...

ProKidney (NASDAQ:PROK) Raised to "Strong-Buy" at Jefferies Financial Group

Jefferies Financial Group upgraded shares of ProKidney to a "strong-buy" rating in a research note on Wednesday...

ProKidney (NASDAQ:PROK) Releases Quarterly Earnings Results, Beats Estimates By $0.03 EPS

ProKidney (NASDAQ:PROK - Get Free Report) announced its quarterly earnings results on Wednesday. The company reported ($0.13) EPS for the quarter, beating analysts' consensus estimates of ($0.16) by...

ProKidney (NASDAQ:PROK) Stock Price Down 4.7% - Time to Sell?

ProKidney (NASDAQ:PROK) Shares Down 4.7% - What's Next...

ProKidney Corp. is a clinical-stage biotechnology company, which engages in the development of a proprietary cell therapy platform. The firm focuses on the treatment of chronic kidney disease, shifting the emphasis away from management of kidney failure to the restoration of kidney function to stop or delay progression of CKD. It offers REACT, a product candidate that includes selected renal cells prepared from a patient's own, autologous, and renal cells. The company was founded on December 21, 2015 and is headquartered in Winston-Salem, NC.

PROK
ProKidney Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest PROK News

PROKProKidney Corp